Once-Daily Mammalian Target of Rapamycin Inhibition as an Alternative to Mycophenolic Acid in High-Risk Pediatric Kidney Transplant Recipients on Belatacept

Abigail M. Schnaith, Emory University School of Medicine, Atlanta, GA, United States; Meredith T. Combs, Children's Healthcare of Atlanta, Atlanta, GA, United States; Brittney Grabowski, Children's Healthcare of Atlanta, Atlanta, GA, United States; Robert Achram, Emory University School of Medicine, Atlanta, GA, United States; Jackson Londeree, Emory University School of Medicine, Atlanta, GA, United States; Carissa Hayes, Children's Healthcare of Atlanta, Atlanta, GA, United States; Elizabeth LaHaie, Children's Healthcare of Atlanta, Brookhaven, GA, United States; Roshan George, Emory University & Children's Healthcare of Atlanta of Atlanta, Atlanta, GA, United States; Rouba Garro, Emory University School of Medicine, Atlanta, GA, United States